Kedalion Therapeutics is Drug Delivery in United States that focus on side effect profile business. Founded in 2015. They cover business area such as developer, an ophthalmic therapy technology, transformative topical ophthalmic drug, new and existing indication, topical drug, comparable efficacy, dose, standard drop, patient comfort, convenience, self-administration, healthcare professional, physician, more comfort, few side effect.
2015
( 11 years old in 2026 )
Side Effect Profile
-
1440 O'Brien Drive
Suite D
Menlo Park, CA 94025
United States
Private
developeran ophthalmic therapy technologytransformative topical ophthalmic drugnew and existing indicationtopical drugcomparable efficacydosestandard droppatient comfortconvenienceself-administrationhealthcare professionalphysicianmore comfortfew side effect
* We use standard office opening hours in near Kedalion Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Kedalion Therapeutics is Drug Delivery business from United States that founded in 2015 (11 years old in 2026), Kedalion Therapeutics business is focusing on Side Effect Profile.
Kedalion Therapeutics headquarter office and corporate office address is located in 1440 O'Brien Drive Suite D Menlo Park, CA 94025 United States.
Kedalion Therapeutics was founded in United States.
In 2026, Kedalion Therapeutics is currently focus on side effect profile sector.
Above is snippet of Google Trends for "side effect profile" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Kedalion Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
